Exploring sub-optimal response to tumour necrosis factor inhibitors in axial spondyloarthritis

THU0347 Impact of obesity on the response to tumour necrosis factor inhibitors in axial spondyloarthritis

10.1136/annrheumdis-2017-eular.2703 ◽

2017 ◽

Author(s):

R Micheroli ◽

M Hebeisen ◽

A Scherrer ◽

L Wildi ◽

P Exer ◽

...

Keyword(s):

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Axial Spondyloarthritis ◽

115. SURVIVAL ANALYSIS AND REASONS FOR DISCONTINUING OR SWITCHING TUMOUR NECROSIS FACTOR INHIBITORS IN AXIAL SPONDYLOARTHRITIS: FINDINGS FROM A REAL-LIFE UK COHORT

Rheumatology ◽

10.1093/rheumatology/kex062.115 ◽

2017 ◽

Vol 56 (suppl_2) ◽

Author(s):

Fariz Yahya ◽

Karl Gaffney ◽

Ellie Lonsdale ◽

Jane Leeder ◽

Alan Brooksby ◽

...

Keyword(s):

Survival Analysis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Axial Spondyloarthritis ◽

Real Life ◽

Disease activity is associated with spinal radiographic progression in axial spondyloarthritis independently of exposure to tumour necrosis factor inhibitors

Rheumatology ◽

10.1093/rheumatology/keaa564 ◽

2020 ◽

Vol 60 (1) ◽

pp. 461-462

Author(s):

Alexandre Sepriano ◽

Sofia Ramiro ◽

Stephanie Wichuk ◽

Praveena Chiowchanwisawakit ◽

Joel Paschke ◽

...

Keyword(s):

Disease Activity ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Radiographic Progression ◽

Axial Spondyloarthritis ◽

Influence of co-morbid fibromyalgia on disease activity measures and response to tumour necrosis factor inhibitors in axial spondyloarthritis: results from a UK national register

Rheumatology ◽

10.1093/rheumatology/key206 ◽

2018 ◽

Vol 57 (11) ◽

pp. 1982-1990 ◽

Cited By ~ 9

Author(s):

Gary J Macfarlane ◽

Ross I R MacDonald ◽

Ejaz Pathan ◽

Stefan Siebert ◽

Karl Gaffney ◽

...

Keyword(s):

Disease Activity ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Axial Spondyloarthritis ◽

National Register ◽

Activity Measures ◽

Necrosis Factor ◽

Disease Activity Measures

Discontinuing tumour necrosis factor inhibitors in non-radiographic axial spondyloarthritis

The Lancet ◽

10.1016/s0140-6736(18)31440-5 ◽

2018 ◽

Vol 392 (10142) ◽

pp. 98-100 ◽

Cited By ~ 1

Author(s):

Jürgen Braun

Keyword(s):

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Axial Spondyloarthritis ◽

Smoking status and cause-specific discontinuation of tumour necrosis factor inhibitors in axial spondyloarthritis

Arthritis Research & Therapy ◽

10.1186/s13075-019-1958-z ◽

2019 ◽

Vol 21 (1) ◽

Cited By ~ 2

Author(s):

Sizheng Steven Zhao ◽

Kazuki Yoshida ◽

Gareth T. Jones ◽

David M. Hughes ◽

Stephen J. Duffield ◽

...

Keyword(s):

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Axial Spondyloarthritis ◽

Smoking Status ◽

Faculty Opinions recommendation of The effectiveness of leflunomide as a co-therapy of tumour necrosis factor inhibitors in rheumatoid arthritis: a population-based study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1104777.560749 ◽

2008 ◽

Author(s):

Geoff Littlejohn

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Population Based ◽

Population Based Study ◽

Therapeutic use of specific tumour necrosis factor inhibitors in inflammatory diseases including COVID-19

Biomedicine & Pharmacotherapy ◽

10.1016/j.biopha.2021.111785 ◽

2021 ◽

pp. 111785

Author(s):

Serena Patel ◽

Meenu Wadhwa

Keyword(s):

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Inflammatory Diseases ◽

Therapeutic Use ◽

Impact of persistence with tumour necrosis factor inhibitors on healthcare resource utilization and costs in chronic inflammatory joint diseases

British Journal of Clinical Pharmacology ◽

10.1111/bcp.14387 ◽

2020 ◽

Cited By ~ 1

Author(s):

Manon Belhassen ◽

Florence Tubach ◽

Christophe Hudry ◽

Macha Woronoff‐Lemsi ◽

Laurie Levy‐Bachelot ◽

...

Keyword(s):

Tumour Necrosis Factor ◽

Resource Utilization ◽

Tumour Necrosis ◽

Healthcare Resource ◽

Healthcare Resource Utilization ◽

Joint Diseases ◽

Inflammatory Joint Diseases ◽

Immediate treatment with tumour necrosis factor inhibitors in synthetic disease-modifying anti-rheumatic drugs-naïve patients with rheumatoid arthritis: results of a modified Italian Expert Consensus

Rheumatology ◽

10.1093/rheumatology/key076 ◽

2018 ◽

Vol 57 (Supplement_7) ◽

pp. vii32-vii41

Author(s):

Alessandra Bortoluzzi ◽

Guido Valesini ◽

Salvatore D’Angelo ◽

Bruno Frediani ◽

Laura Bazzichi ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Expert Consensus ◽

Disease Modifying ◽